Literature DB >> 17878253

GPR30 estrogen receptor expression in the growth plate declines as puberty progresses.

Andrei S Chagin1, Lars Sävendahl.   

Abstract

OBJECTIVE: Our objective was to study whether GPR30 is expressed in the epiphyseal growth plate and its potential role as a modulator of pubertal growth.
BACKGROUND: Estrogens play a crucial role in the regulation of skeletal maturation and longitudinal bone growth. We have previously shown that both estrogen receptors (ERs) alpha and beta are expressed in the human epiphyseal growth plate. Recently, a membrane-bound ER referred to as GPR30 was discovered, but the role played by this receptor in the regulation of longitudinal bone growth is not yet known. PATIENTS/
METHODS: Biopsies were collected from the tibial growth plates of 14 boys and seven girls that underwent epiphyseal surgery to arrest longitudinal bone growth. The patients were in different stages of puberty and suffered from inequality in leg length or extreme tall stature. Paraffin-embedded sections of the growth plates were used to detect expression of the GPR30 protein.
RESULTS: The highest level of GPR30 expression was observed in hypertrophic chondrocytes, although cells with positive immunostaining were also detected in the resting zone. In contrast, no immunoreactivity was found in the proliferative zone. During pubertal progression there was a clear decline in the level of GPR30 expression in both boys and girls.
CONCLUSIONS: The novel ER GPR30 is expressed in the human growth plate, and the level of expression declines during pubertal progression. Although a relationship between GPR30 expression and age may underlie the observed pubertal decline in the GPR30 level, our observations suggest that this receptor could be involved in the modulation of longitudinal bone growth during puberty.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17878253     DOI: 10.1210/jc.2007-0814

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  25 in total

1.  Genomic polymorphisms of G-protein estrogen receptor 1 are associated with severity of adolescent idiopathic scoliosis.

Authors:  Yan Peng; Guoyan Liang; Yuanyuan Pei; Wei Ye; Anjing Liang; Peiqiang Su
Journal:  Int Orthop       Date:  2011-10-16       Impact factor: 3.075

2.  Unique ERalpha cistromes control cell type-specific gene regulation.

Authors:  Susan A Krum; Gustavo A Miranda-Carboni; Mathieu Lupien; Jerome Eeckhoute; Jason S Carroll; Myles Brown
Journal:  Mol Endocrinol       Date:  2008-09-25

Review 3.  What have we learned about GPER function in physiology and disease from knockout mice?

Authors:  Eric R Prossnitz; Helen J Hathaway
Journal:  J Steroid Biochem Mol Biol       Date:  2015-07-16       Impact factor: 4.292

Review 4.  Role of G-proteins in the differentiation of epiphyseal chondrocytes.

Authors:  Andrei S Chagin; Henry M Kronenberg
Journal:  J Mol Endocrinol       Date:  2014-06-30       Impact factor: 5.098

Review 5.  The molecular mechanisms underlying the pharmacological actions of estrogens, SERMs and oxysterols: implications for the treatment and prevention of osteoporosis.

Authors:  Erik R Nelson; Suzanne E Wardell; Donald P McDonnell
Journal:  Bone       Date:  2012-11-17       Impact factor: 4.398

6.  Bone age advancement in prepubertal children with obesity and premature adrenarche: possible potentiating factors.

Authors:  Aviva B Sopher; Amy M Jean; Sarah K Zwany; Diana M Winston; Christy B Pomeranz; Jennifer J Bell; Donald J McMahon; Abeer Hassoun; Ilene Fennoy; Sharon E Oberfield
Journal:  Obesity (Silver Spring)       Date:  2011-02-10       Impact factor: 5.002

7.  Slipped capital femoral epiphysis and its association with endocrine, metabolic and chronic diseases: a systematic review of the literature.

Authors:  M Witbreuk; F J van Kemenade; J A van der Sluijs; E P Jansma; J Rotteveel; B J van Royen
Journal:  J Child Orthop       Date:  2013-03-30       Impact factor: 1.548

Review 8.  Recent experimental and clinical findings in the skeleton associated with loss of estrogen hormone or estrogen receptor activity.

Authors:  Eric P Smith; Bonny Specker; Kenneth S Korach
Journal:  J Steroid Biochem Mol Biol       Date:  2009-11-10       Impact factor: 4.292

9.  The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells.

Authors:  Eric A Ariazi; Eugen Brailoiu; Smitha Yerrum; Heather A Shupp; Michael J Slifker; Heather E Cunliffe; Michael A Black; Anne L Donato; Jeffrey B Arterburn; Tudor I Oprea; Eric R Prossnitz; Nae J Dun; V Craig Jordan
Journal:  Cancer Res       Date:  2010-01-19       Impact factor: 12.701

10.  Runx2 regulates G protein-coupled signaling pathways to control growth of osteoblast progenitors.

Authors:  Nadiya M Teplyuk; Mario Galindo; Viktor I Teplyuk; Jitesh Pratap; Daniel W Young; David Lapointe; Amjad Javed; Janet L Stein; Jane B Lian; Gary S Stein; Andre J van Wijnen
Journal:  J Biol Chem       Date:  2008-07-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.